Faus Moliner, Autor en Faus & Moliner Abogados

Cohesión en la regulación de nuevos alimentos: buenas noticias para los derivados del cannabis

Anna Gerboles

18 Sep 2023

El Global

El medicamento en lo tribunales en el año 2022

Anna Gerboles, Jordi Faus, Xavier Moliner, Eduard Rodellar, Lluís Alcover, Santiago Tomas, Juan Martínez, Joan Carles Bailach, Laia Rull and Claudia Gonzalo

8 Sep 2023

COMUNICACIONES EN PROPIEDAD INDUSTRIAL Y DERECHO DE LA COMPETENCIA, NÚM. 98 ENERO-ABRIL 2023

Faus Moliner participates in “Chambers Global Practices Guides Medical Cannabis & Cannabinoid Regulation 2023”

Anna Gerboles writes about the regulation of medical cannabis and cannabinoids in Spain

Anna Gerboles

27 Jun 2023

CHAMBERS GLOBAL PRACTICE GUIDES

The Pharma Legal Handbook: Spain

Faus & Moliner has participated in the publication of the Spanish chapter of the The Pharma Legal Handbook guide, edited by PharmaBoardroom

Anna Gerboles, Eduard Rodellar, Lluís Alcover, Joan Carles Bailach and Juan Martínez

23 Jun 2023

THE PHARMA LEGAL HANDBOOK

Telemedicine: A global approach to trends and practices

Faus Moliner participates in the preparation of the guide on the regulation of telemedicine services in Spain

Anna Gerboles, Eduard Rodellar and Jordi Faus

1 Jun 2023

Sobre la consulta del nuevo Real Decreto de publicidad

Anna Gerboles

24 Apr 2023

El Global

Faus & Moliner participates in the “Chambers Global Practices Guides – Pharmaceutical Advertising 2023″

Jordi Faus, Anna Gerbolés y Claudia Alberdi write the chapter about Law and Practice in Spain

Anna Gerboles, Claudia Alberdi and Jordi Faus

30 Mar 2023

Ratification of the principle of primacy of application of the legal regime on medicinal products

Judgment of the Court of Justice of the European Union of 19 January 2023 in cases C-495/21 and C-496/21

Anna Gerboles

16 Mar 2023

Capsulas Nº 236

Afinando la frontera entre medicamentos y productos sanitarios

Anna Gerboles

13 Feb 2023

El Global

El impacto de los canales digitales y redes sociales en la promoción de medicamentos. Panorama normativo y nuevas herramientas de Control

Anna Gerboles

16 Dec 2022

Cohesión en la regulación de nuevos alimentos: buenas noticias para los derivados del cannabis

El Global

El medicamento en lo tribunales en el año 2022

COMUNICACIONES EN PROPIEDAD INDUSTRIAL Y DERECHO DE LA COMPETENCIA, NÚM. 98 ENERO-ABRIL 2023

Faus Moliner participates in “Chambers Global Practices Guides Medical Cannabis & Cannabinoid Regulation 2023”

Anna Gerboles writes about the regulation of medical cannabis and cannabinoids in Spain

CHAMBERS GLOBAL PRACTICE GUIDES

The Pharma Legal Handbook: Spain

Faus & Moliner has participated in the publication of the Spanish chapter of the The Pharma Legal Handbook guide, edited by PharmaBoardroom

THE PHARMA LEGAL HANDBOOK

Telemedicine: A global approach to trends and practices

Faus Moliner participates in the preparation of the guide on the regulation of telemedicine services in Spain

Sobre la consulta del nuevo Real Decreto de publicidad

El Global

Faus & Moliner participates in the “Chambers Global Practices Guides – Pharmaceutical Advertising 2023″

Jordi Faus, Anna Gerbolés y Claudia Alberdi write the chapter about Law and Practice in Spain

Ratification of the principle of primacy of application of the legal regime on medicinal products

Judgment of the Court of Justice of the European Union of 19 January 2023 in cases C-495/21 and C-496/21

Capsulas Nº 236

Afinando la frontera entre medicamentos y productos sanitarios

El Global

El impacto de los canales digitales y redes sociales en la promoción de medicamentos. Panorama normativo y nuevas herramientas de Control

CUADERNOS DE DERECHO FARMACÉUTICO, NUM. 83, OCTOBER-DECEMBER 2022

Uso de cookies